← FDA DRUG APPROVALS

FDA ANDA · ANDA065143

CEFAZOLIN

Sponsor: HIKMA FARMACEUTICA

APPLICATION
ANDA065143
TYPE
ANDA
ORIGINAL APPROVAL
2004-10-18
LATEST ACTION
2012-01-11
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

CEFAZOLIN SODIUMPrescription
CEFAZOLIN SODIUM EQ 10GM BASE/VIAL · INJECTABLE · INJECTION

Approval history

2012-01-11Manufacturing (CMC) · Supplement 8AP
2004-10-18OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →